Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19

April 22, 2020Press Releases

CHARLOTTESVILLE, Va., April 22, 2020 /PRNewswire/ — Biovista, a privately-held AI / bioscience firm best known for drug repositioning, has identified four treatments – two prescription drugs and two over-the-counter compounds — to counter key symptoms of COVID-19. “Drug AI helps find that needle in the haystack, and we are optimistic that we have found four … Read More

Biovista expands Project Prodigy collaborations in personalized medicine

August 11, 2017Press Releases

Biovista and Hewlett Packard Enterprise to collaborate on next generation AI and Big Data Analytics to advance real-world personalized medicine at community hospital settings. CHARLOTTESVILLE, Va., Aug. 10, 2017 /PRNewswire/ — Biovista announced today that it is collaborating with HPE to advance Biovista’s Project Prodigy Big Data AI healthcare platform applied in the personalized medicine … Read More

Sarah Bush Lincoln to Use Biovista’s Project Prodigy Artificial Intelligence Engine to Identify and Validate New Therapeutic Options for Further Research

January 19, 2017Press Releases

Charlottesville, VA (PRWEB) January 19, 2017 Sarah Bush Lincoln (SBL), a hospital and health care organization that is home to more than 300,000 provider office visits per year, and Biovista announced today that they will be working together to validate novel therapeutic options generated in the real-world practice of a hospital and health center, using … Read More

Biovista announces strong preclinical results for two drugs targeting Niemann-Pick Disease Type A

January 12, 2017Press Releases

CHARLOTTESVILLE, Va. – Jan. 12, 2017 – Biovista Inc. today announced that two drugs targeting Niemann-Pick Disease Type A (NPA), have shown strong positive results in the Acid Sphingomyelinase ASM knock-out (ASMKO) mouse model. Both repositioning candidates (BVA-901A and BVA-901B) tested by the laboratory of Dr. M.D. Ledesma at the Madrid Center for Molecular Biology … Read More

Biotrend Chemikalien GmbH awards contract to Biovista Inc. for its Vizit literature search tool

November 3, 2016Press Releases, Vizit Blog

Charlottesville, VA, November 3rd, 2016 — Biovista Inc. today announced the signing of a contract with Biotrend Chemikalien GmbH1 for access to Biovista’s2 Vizit3 visual search engine. Biotrend will be offering Vizit as a free resource to visitors of its web site. Vizit is a visual search engine of PubMed articles that allows researchers and … Read More